MARKET

EPRX

EPRX

Eupraxia Pharmac
NASDAQ
3.540
-0.100
-2.75%
After Hours: 3.780 +0.24 +6.78% 19:01 03/25 EDT
OPEN
3.670
PREV CLOSE
3.640
HIGH
3.680
LOW
3.500
VOLUME
25.72K
TURNOVER
--
52 WEEK HIGH
4.480
52 WEEK LOW
2.200
MARKET CAP
126.91M
P/E (TTM)
-6.4942
1D
5D
1M
3M
1Y
5Y
1D
Weekly Report: what happened at EPRX last week (0317-0321)?
Weekly Report · 1d ago
Raymond James Sticks to Their Buy Rating for Eupraxia Pharmaceuticals (EPRX)
TipRanks · 1d ago
Eupraxia Pharmaceuticals reports Q4 results
Seeking Alpha · 4d ago
Eupraxia Pharmaceuticals Reports Strong Q4 2024 Results and Operational Progress
TipRanks · 5d ago
Eupraxia Pharmaceuticals Q4 Net Profit $(7.5)M Up From $(10.6)M YoY
Benzinga · 5d ago
EUPRAXIA PHARMACEUTICALS REPORTS FOURTH QUARTER 2024 FINANCIAL RESULTS
Reuters · 5d ago
Weekly Report: what happened at EPRX last week (0310-0314)?
Weekly Report · 03/17 12:32
Weekly Report: what happened at EPRX last week (0303-0307)?
Weekly Report · 03/10 12:34
More
About EPRX
Eupraxia Pharmaceuticals Inc. is a Canada-based clinical-stage biotechnology company. The Company is focused on the development of locally delivered, extended-release products. The Company’s lead product candidate, EP-104, is designed to address the significant unmet medical need and market demand for conditions where long-lasting symptom relief is essential to effective treatment. The primary targets for EP-104 have been identified as knee osteoarthritis (OA) and eosinophilic esophagitis (EoE). The product in development for OA is called EP-104IAR and the product in development in EoE is called EP-104GI. DiffuSphere, a proprietary, polymer based micro-sphere technology, is designed to facilitate targeted drug delivery, with extended duration of effect, and offers multiple, highly tunable pharmacokinetic (PK) profiles.

Webull offers Eupraxia Pharmaceuticals Inc stock information, including NASDAQ: EPRX real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, EPRX stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading EPRX stock methods without spending real money on the virtual paper trading platform.